
Although demand for Bharat Biotech’s Covaxin is high with many senior citizens preferring it over Covishield, there is very little information on where doses of the made-in-India vaccine are being administered.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3c2dRC8
via
IFTTT
0 comments:
Post a Comment